US Stock MarketDetailed Quotes

ZURA Zura Bio

Watchlist
  • 4.460
  • -0.420-8.61%
Close Jun 4 16:00 ET
  • 4.590
  • +0.130+2.91%
Post 16:02 ET
284.03MMarket Cap-3231P/E (TTM)

Zura Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
8.55%8.38M
130.61%62.64M
10.83M
10.19M
33.91M
7.72M
2,956.91%27.16M
888.55K
Selling and administrative expenses
68.82%4.79M
436.68%18.64M
--3.91M
--6.22M
--5.68M
--2.84M
290.86%3.47M
--888.55K
-General and administrative expense
68.82%4.79M
436.68%18.64M
--3.91M
--6.22M
--5.68M
--2.84M
290.86%3.47M
--888.55K
Research and development costs
-26.43%3.59M
85.74%44M
--6.92M
--3.97M
--28.23M
--4.88M
--23.69M
----
Operating profit
-8.55%-8.38M
-130.61%-62.64M
-10.83M
-10.19M
-33.91M
-7.72M
-2,956.91%-27.16M
-888.55K
Net non-operating interest income expense
121,400.00%1.22M
27,225.00%2.19M
1.37M
815K
1K
15,586.27%8K
51
Non-operating interest income
121,400.00%1.22M
27,225.00%2.19M
--1.37M
--815K
----
--1K
15,586.27%8K
--51
Other net income (expense)
71.93%-583K
37.99%-111K
984K
1.1M
-120K
-2.08M
-102.31%-179K
7.74M
Gain on sale of security
-442.37%-606K
--2.12M
--960K
--1.11M
---532K
--177K
----
--7.74M
Other non- operating income (expenses)
101.02%23K
-1,144.13%-2.23M
--24K
---4K
--412K
---2.25M
---179K
----
Income before tax
20.91%-7.75M
-121.57%-60.56M
-8.47M
-8.27M
-34.03M
-9.8M
-499.10%-27.33M
6.85M
Income tax
0
0
0
0
0
0
Net income
20.91%-7.75M
-121.57%-60.56M
-8.47M
-8.27M
-34.03M
-9.8M
-499.10%-27.33M
6.85M
Net income continuous Operations
20.91%-7.75M
-121.57%-60.56M
---8.47M
---8.27M
---34.03M
---9.8M
-499.10%-27.33M
--6.85M
Minority interest income
0
87.27%-203K
0
0
0
-203K
-1.6M
Net income attributable to the parent company
19.23%-7.75M
-134.52%-60.36M
-8.47M
-8.27M
-34.03M
-9.59M
-475.81%-25.74M
6.85M
Preferred stock dividends
Other preferred stock dividends
-3,556.65%-7.02M
33.54%8.88M
-1.99M
0
203K
6.65M
Net income attributable to common stockholders
92.55%-730K
-113.78%-69.24M
-6.28M
-8.27M
-34.03M
-9.8M
-572.94%-32.39M
6.85M
Basic earnings per share
99.28%-0.02
98.53%-2.09
0.13
-0.18
-1.31
-2.76
-572.94%-141.97
30.0184
Diluted earnings per share
99.28%-0.02
98.53%-2.09
-0.144
-0.18
-1.31
-2.76
-572.94%-141.97
30.0184
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Total revenue 00000000
Operating revenue --0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 8.55%8.38M130.61%62.64M10.83M10.19M33.91M7.72M2,956.91%27.16M888.55K
Selling and administrative expenses 68.82%4.79M436.68%18.64M--3.91M--6.22M--5.68M--2.84M290.86%3.47M--888.55K
-General and administrative expense 68.82%4.79M436.68%18.64M--3.91M--6.22M--5.68M--2.84M290.86%3.47M--888.55K
Research and development costs -26.43%3.59M85.74%44M--6.92M--3.97M--28.23M--4.88M--23.69M----
Operating profit -8.55%-8.38M-130.61%-62.64M-10.83M-10.19M-33.91M-7.72M-2,956.91%-27.16M-888.55K
Net non-operating interest income expense 121,400.00%1.22M27,225.00%2.19M1.37M815K1K15,586.27%8K51
Non-operating interest income 121,400.00%1.22M27,225.00%2.19M--1.37M--815K------1K15,586.27%8K--51
Other net income (expense) 71.93%-583K37.99%-111K984K1.1M-120K-2.08M-102.31%-179K7.74M
Gain on sale of security -442.37%-606K--2.12M--960K--1.11M---532K--177K------7.74M
Other non- operating income (expenses) 101.02%23K-1,144.13%-2.23M--24K---4K--412K---2.25M---179K----
Income before tax 20.91%-7.75M-121.57%-60.56M-8.47M-8.27M-34.03M-9.8M-499.10%-27.33M6.85M
Income tax 000000
Net income 20.91%-7.75M-121.57%-60.56M-8.47M-8.27M-34.03M-9.8M-499.10%-27.33M6.85M
Net income continuous Operations 20.91%-7.75M-121.57%-60.56M---8.47M---8.27M---34.03M---9.8M-499.10%-27.33M--6.85M
Minority interest income 087.27%-203K000-203K-1.6M
Net income attributable to the parent company 19.23%-7.75M-134.52%-60.36M-8.47M-8.27M-34.03M-9.59M-475.81%-25.74M6.85M
Preferred stock dividends
Other preferred stock dividends -3,556.65%-7.02M33.54%8.88M-1.99M0203K6.65M
Net income attributable to common stockholders 92.55%-730K-113.78%-69.24M-6.28M-8.27M-34.03M-9.8M-572.94%-32.39M6.85M
Basic earnings per share 99.28%-0.0298.53%-2.090.13-0.18-1.31-2.76-572.94%-141.9730.0184
Diluted earnings per share 99.28%-0.0298.53%-2.09-0.144-0.18-1.31-2.76-572.94%-141.9730.0184
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg